Zhonghao Li

ORCID: 0000-0003-0699-300X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ionic liquids properties and applications
  • Nonlinear Photonic Systems
  • Electrocatalysts for Energy Conversion
  • Advanced Fiber Laser Technologies
  • Nonlinear Waves and Solitons
  • Mesoporous Materials and Catalysis
  • Nanoplatforms for cancer theranostics
  • Electrochemical Analysis and Applications
  • Catalytic Processes in Materials Science
  • Nanoparticle-Based Drug Delivery
  • Advanced battery technologies research
  • Analytical Chemistry and Chromatography
  • Supercapacitor Materials and Fabrication
  • Catalysis for Biomass Conversion
  • Phase Equilibria and Thermodynamics
  • Quantum Dots Synthesis And Properties
  • Advanced Photocatalysis Techniques
  • Gas Sensing Nanomaterials and Sensors
  • ZnO doping and properties
  • Nanomaterials for catalytic reactions
  • Catalysis and Oxidation Reactions
  • Graphene research and applications
  • Surfactants and Colloidal Systems
  • Analytical Chemistry and Sensors
  • Graphene and Nanomaterials Applications

Shandong University
2016-2025

Northeast Forestry University
2023-2025

Beijing Academy of Science and Technology
2023-2025

Interface (United States)
2015-2025

Tianmu Lake Institute of Advanced Energy Storage Technologies (China)
2024

Qingdao University of Technology
2024

South China Normal University
2023-2024

State Grid Corporation of China (China)
2024

Qingdao University of Science and Technology
2022-2024

Beijing Institute of Petrochemical Technology
2024

Abstract Zeolitic imidazolate framework‐8 (ZIF‐8) is an attractive metal organic framework (MOF) in drug delivery. Strong interaction between drugs and ZIF‐8 essential for high loadings through situ construction of MOFs. However, only limited with unique functional groups (COOH, SO 3 H, et al.) can interact be encapsulated satisfactorily so far. Drugs without these are difficult to loaded due the lack strong interaction. Herein a versatile prodrug strategy proposed solve problems...

10.1002/adfm.201802830 article EN Advanced Functional Materials 2018-07-01

Conventional organic and inorganic drug nanocarriers suffer from serious drawbacks such as low drug-storage capacity uncontrolled release. Moreover, multidrug resistance (MDR) has been one of the primary causes leading to chemotherapy failure for cancers. The main reason MDR is overexpressed active efflux transporters P-glycoprotein. Here, zeolitic imidazolate framework ZIF-8, biocompatible metal frameworks (MOFs), reported first time carrier realizing efficient codelivery verapamil...

10.1021/acsami.7b05142 article EN ACS Applied Materials & Interfaces 2017-05-22

Both ionic liquids and water are typical green solvents. In this work, the phase behavior of ternary system consisting liquid 1-butyl-3-methylimidazolium hexafluorophosphate (bmimPF6), TX-100, was determined at 25.0 degrees C. The water-in-bmimPF6, bicontinuous, bmimPF6-in-water microregions microemulsions were identified by cyclic voltammetry method using potassium ferrocyanide K4Fe(CN)6 as electroactive probe. Dynamic light scattering (DLS) UV-vis used to characterize microemulsions. It...

10.1021/la0500880 article EN Langmuir 2005-05-25

Ionic liquids (ILs) can add value to many chemical processes. The electrochemistry and the (physical) organic chemistry communities in particular have extensively studied structure, properties, reactivities of various ILs reactions therein. Inorganic materials chemists are newest addition IL community: over a number years, approaches fabrication inorganic solids with unprecedented sometimes unique structures properties been reported. This article summarizes state this sub-field research...

10.1039/b616593a article EN Dalton Transactions 2006-12-19

Large-size single-crystal gold nanosheets have been successfully prepared by microwave heating of HAuCl(4) in ionic liquid, 1-butyl-3-methylimidazolium tetrafluoroborate, without any additional template agent. Transmission electron microscopy (TEM), diffraction (ED), scanning (SEM), and X-ray powder (XRD) were used to characterize the resultant nanosheets. It was demonstrated that liquid could act as agent for formation The present synthesis route is very simple fast. can be expected method...

10.1021/jp0520998 article EN The Journal of Physical Chemistry B 2005-07-06

We present new types of solitary wave solutions for the higher order nonlinear Schr\"odinger (HNLS) equation describing propagation femtosecond light pulses in an optical fiber under certain parametric conditions. Unlike reported HNLS equation, novel ones can describe bright and dark properties same expressions their amplitude may approach nonzero when time variable approaches infinity. In addition, such cannot exist equation. Furthermore, we investigate stability these waves some initial...

10.1103/physrevlett.84.4096 article EN Physical Review Letters 2000-05-01

10.1016/j.cossms.2009.01.002 article EN Current Opinion in Solid State and Materials Science 2008-02-01

Quercetin (QT) is one promising candidate for the treatment of various cancers with virtually no toxic side effects. However, its anticancer effect severely restricted by poor bioavailability, low water solubility, and chemical instability in neutral alkaline medium. Herein, zeolitic imidazolate framework-8 (ZIF-8) first reported as multifunctional nanoplatform to codelivery quercetin an agent CuS nanoparticles a photothermal therapy (PTT) synergistic combination chemotherapy PTT well...

10.1021/acsami.8b13487 article EN ACS Applied Materials & Interfaces 2018-09-14

This review provides a holistic overview of the developed heterogeneous catalysts for HMF production from dehydration glucose and cellulose in various solvent systems.

10.1039/c6ra20547j article EN RSC Advances 2016-01-01

The antitumor immune response involves a cascade of three phases, namely, antigen presentation (Phase I), lymphocyte activation and proliferation/differentiation II), tumor elimination III). Therefore, an ideal immunotherapy nanoplatform is one that can simultaneously execute these phases. However, it great challenge to develop single which deliver individual immunoagent their on-demand target sites for tailoring phases because the different restricted by Herein, first time we reported...

10.1021/acs.nanolett.9b02923 article EN Nano Letters 2019-08-14

Hierarchically structured one-dimensional (1D) MoO2 is synthesized for the first time in ionic liquid 1-butyl-3-methylimidazolium bis(trifluoromethanesulfonyl)imide ([BMIM][Tf2N]). The synthesis system very simple (single [BMIM][Tf2N] solvent plus MoO2(acac)2 reactant). itself works as both reaction medium and template formation of these interesting 1D particles with ultrathin nanosheet subunits. as-synthesized hierarchically MoO2_40 exhibit remarkable electrocatalytic activity good...

10.1021/acsami.7b00722 article EN ACS Applied Materials & Interfaces 2017-02-10

Abstract Phototherapy as a promising cancer diagnostic and therapeutic strategy has aroused extensive attention. However, single‐wavelength near‐infrared (NIR) light–triggered combinational treatment of photothermal therapy (PTT) photodynamic (PDT) is still great challenge. Herein, multifunctional micelle activated by laser for simultaneous PTT PDT well fluorescence imaging developed. Briefly, new indocyanine green (IR820) conjugated to d ‐α‐tocopheryl polyethylene glycol 1000 succinate...

10.1002/smll.201802994 article EN Small 2018-11-26

The concept of integrating immunogenic cell death (ICD) with tailoring the immunosuppressive tumor microenvironment (TME) is promising for immunotherapy. Photothermal therapy (PTT) could efficiently induce ICD, while an indoleamine 2,3-dioxygenase (IDO) inhibitor convert "cold" TME. Therefore, combination PTT and IDO attractive approach Unfortunately, rarely reported. Herein, organic photothermal agent IR820 1-methyl-tryptophan (1MT) were, first time, designed to be all-rolled-into-one...

10.1021/acsami.9b09568 article EN ACS Applied Materials & Interfaces 2019-08-20

The short lifetime and easy quick elimination of the near-infrared (NIR) dye new indocyanine green (IR820) in body restrict its practical application as a photothermal agent cancer therapy. Meanwhile, drawback poor water solubility chemotherapeutic drug paclitaxel (PTX) largely restricts clinical applications. Herein, we, for first time, combined IR820 PTX an "all-in-one" fluorescence imaging-guided chemo–photothermal therapy (PTT) platform by rational design novel pH- enzyme-sensitive...

10.1021/acsami.8b09098 article EN ACS Applied Materials & Interfaces 2018-08-17

A task-specific ionic liquid strategy was, for the first time, proposed designing oxygen vacancy-rich α-Fe2O3 nanocubes toward electrocatalytic N2 fixation to NH3 under ambient conditions, offering a formation rate of 32.13 μg h-1 mgcat-1 with faradaic efficiency 6.63% at -0.3 V vs. reversible hydrogen electrode.

10.1039/c9cc03221e article EN Chemical Communications 2019-01-01

Abstract Current programmed death‐1 ligand (PD‐L1)‐based therapy focuses on local tumors. However, circulating exosomal PD‐L1 possesses inherent anti‐PD‐L1 blockade resistance and dominates tumor metastasis, playing a critical role in systemic immunosuppression. Therefore, the efficacy of immune checkpoint depends simultaneously decreasing tumoral PD‐L1. such therapeutic platforms have never been reported so far. Herein, checkpoint‐regulatable niche created by an injectable hydrogel is to...

10.1002/adfm.202104630 article EN Advanced Functional Materials 2021-06-26

The solubilities of beta-cyclodextrin (beta-CD), ionic liquid (IL) 1-butyl-3-methylimidazolium hexafluorophosphate (bmimPF6), and their mixture in water were determined, the conductivity these aqueous solutions was measured. It demonstrated that beta-CD bmimPF6 could enhance solubility each other, curves linear with gradients about 1. decreased remarkably increasing concentration, a discernible break curve be observed when equimolar solution. results indicated inclusion complexes (ICs) 1:1...

10.1002/chem.200500120 article EN Chemistry - A European Journal 2005-07-22
Coming Soon ...